BCNU 7.7 MG Drug Implant
- RxCUI
- 309013
- RxNorm name
- BCNU 7.7 MG Drug Implant
- Display name
- BCNU 7.7 MG Drug Implant
- Full name
- BCNU 7.7 MG Drug Implant
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:54
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gliadel | CARMUSTINE | Azurity Pharmaceuticals, Inc. | 38962a55-a514-4c48-bea5-f99a8da4beec | 2024-12-05 | Warnings, Adverse reactions | 309013 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 38962a55-a514-4c48-bea5-f99a8da4beec | BCNU 7.7 MG Drug Implant | SY | 8 | These highlights do not include all the information needed to use GLIADEL WAFER safely and effectively. See full prescribing information for GLIADEL WAFER. GLIADEL ® WAFER (carmustine implant), for intracranial use Initial U.S. Approval: 1996 | 20241205 |
| 38962a55-a514-4c48-bea5-f99a8da4beec | carmustine 7.7 MG Drug Implant | SCD | 8 | These highlights do not include all the information needed to use GLIADEL WAFER safely and effectively. See full prescribing information for GLIADEL WAFER. GLIADEL ® WAFER (carmustine implant), for intracranial use Initial U.S. Approval: 1996 | 20241205 |
| 38962a55-a514-4c48-bea5-f99a8da4beec | carmustine 7.7 MG Wafer | SY | 8 | These highlights do not include all the information needed to use GLIADEL WAFER safely and effectively. See full prescribing information for GLIADEL WAFER. GLIADEL ® WAFER (carmustine implant), for intracranial use Initial U.S. Approval: 1996 | 20241205 |
| 38962a55-a514-4c48-bea5-f99a8da4beec | carmustine 7.7 MG Intracavitary Drug Implant | PSN | 8 | These highlights do not include all the information needed to use GLIADEL WAFER safely and effectively. See full prescribing information for GLIADEL WAFER. GLIADEL ® WAFER (carmustine implant), for intracranial use Initial U.S. Approval: 1996 | 20241205 |